Unitract Syringe Claims Top World Award For Invention

SYDNEY, April 7 /PRNewswire-FirstCall/ -- Unitract is pleased to announce its advanced syringe technology has been honoured with two of the world's most distinguished awards for innovation at the 32nd International Exhibition of Inventions and New Technologies in Geneva.

The awards are widely regarded as the key annual event to recognise the world's best new inventions. This year a record 675 inventions from 42 countries were exhibited and judged before an array of international specialists. The inventions were also viewed by more than 60,000 visitors, of which more than half were reported to be industrialists, distributors and businessmen seeking to invest and market new inventions.

Unitract was presented with the prestigious Prize of the State of Geneva Award, which is given by the host city to the invention they consider having the greatest potential for commercial success, as well as its overall benefit to humanity. The Unitract Syringe also received a Gold Medal for Best Medical Device, which in itself is a significant tribute for an Australian innovation.

Mr Alan Shortall, Chief Executive of Unitract Ltd, said the Company was honoured to receive such global endorsement of its technology.

"The State of Geneva Award is one of the greatest possible endorsements Unitract could ever hope to receive. It is a recognition and validation of our technology on a truly international stage from some of the world's most brilliant minds. The Gold Medal for Best Medical Device is also very special, considering the high level of competition which existed in the category this year."

"Unitract must especially congratulate its Joint Heads of Research and Development, Craig Thorley and Joe Kaal, for the development of the syringe's core technology. These awards are a particular testament to the drive, dedication and ingenuity which they displayed in developing the next generation of syringe technology."

The Unitract Syringe is the world's first and only known syringe that automatically helps prevent both needlestick injuries and the reuse of syringes. Together these two unsafe injection practices kill more than 1.3 million people a year via the transmission of blood-borne diseases including HIV-AIDS, Hepatitis B and Hepatitis C.

For and on behalf of the Board ALAN SHORTALL Chief Executive Officer

Unitract Ltd

CONTACT: Stephen Allan of Unitract Ltd, +61-2-9251-6566, +61-416-177-287

Back to news